|
|
In response to the COVID-19 public health emergency, the Substance Abuse and Mental Health Services Agency (SAMHSA) made it easier for patients to receive take-home supplies of methadone and buprenorphine. This report by Bridget Dooling & Laura Stanley explores the effects of this policy change, and explains why SAMHSA has the legal authority to extend this flexibility beyond the pandemic to help treat opioid use disorder. |
|
Recent Research, Events, and Media Appearances |
|
|
- President Biden's "modernizing regulatory review" memorandum signals continuity in some areas of regulatory practice and dramatic shifts in others.
|
- In the case of regulatory rollbacks, the Biden administration has been actively using several options to reverse Trump-era rules, including withdrawals, regulatory suspensions, strategic responses to litigation, and other executive actions.
|
- This draft report for ACUS closes with a set of recommendations for agencies to address the challenges and opportunities associated with new technologies that bear on the rulemaking process.
|
- GSA recently replaced the classic version of Regulations.gov with a new, sleek website. This commentary assesses the modernizing efforts and suggests further ways to improve the user experience.
|
|
- Dr. Beales' testimony to the Subcommittee on Consumer Protection and Commerce urged Congress to explicitly authorize the FTC to pursue monetary damages in cases involving dishonest or fraudulent conduct under Section 13(b).
|
- The Democrat-led Congress has targeted six regulations for elimination including actions issued by: the EEOC, EPA. Treasury, HHS, SSA, and SEC.
|
- Building up the ability for agencies to conduct effective benefit-cost analysis was difficult when Clinton authored EO 12866, so too will be building out better distributional analysis under Biden’s recent memorandum. It was worth the effort then, and it will be worth the effort now.
|
- This article examines legislative action on resolutions of disapproval under the CRA by committees, political parties, and congressional majorities.
|
|
|
|
Bridget Dooling discussed what being part of a transition team entails and what it was like leading a change in administrations during a pandemic.
|
|
Upcoming Events:
Recent Events:
|
|
- Features our Economically Significant Final Rules by Presidential Year chart.
|
- "Bridget Dooling said it’s uncertain what might happen if many of the final Trump regulations didn’t go through the proper procedure. She also said it’s up in the air whether using the CRA now would prevent Biden from issuing new rules in the same space."
|
- “Our research has shown that Democrats, like Republicans, have a history of introducing disapproval resolutions under the CRA, which “unsettles the conventional wisdom” that only Republicans use it, they wrote."
|
- "It's hard to know the long-term impact, but any single rule "could entail hundreds of millions, if not billions, of dollars in annual costs and benefits," George Washington University expert Daniel Perez told Axios."
|
|
- "The CRA is such a blunt instrument," said Daniel Pérez. "There are other tools at their disposal."
|
- “On the one hand, a joint vote can quickly overturn Trump regulations with a resolution of disapproval, but on the other hand, that would take time away from other business. Also, the CRA is a blunt tool and disapproval could not only eliminate the Trump regulation, but constrain how the Biden administration approaches those issues.”
|
- Daniel Pérez estimated there may be as many as 1,354 of these rules.
|
- Bridget Dooling is interviewed by Kimberly Adams about the Congressional Review Act.
|
|
- On his first day, Biden “set a new course for the future,” said Bridget Dooling. “By taking these steps on his first day in office, it signals how important it is to get the regulatory machine operating in sync with the president’s vision.”
|
|
|
|
|
|
|
